相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome
Georgios Sogkas et al.
CLINICAL IMMUNOLOGY (2020)
The spectrum of primary immunodeficiencies at a tertiary care hospital in Pakistan
Sonia Qureshi et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2020)
Hyper IgE syndromes: clinical and molecular characteristics
Taha Al-Shaikhly et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway
Rojo A. Ratsimandresy et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Commonality of the IL-4/IL-13 pathway in atopic diseases
Namita A. Gandhi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome
Manish Arora et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2017)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Maurizio Mennini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Nationwide Study of Severe and Protracted Diarrhoea in Patients with Primary Immunodeficiency Diseases
Wen-I Lee et al.
SCIENTIFIC REPORTS (2017)
Early-Life Gut Bacteria Associate with IL-4-, IL-10-and IFN-γ Production at Two Years of Age
Maria A. Johansson et al.
PLOS ONE (2012)
Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome
Alexandra F. Freeman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Geethanjali Pickert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
分享论文
